Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium

[1]  P. Burney,et al.  Determinants of underdiagnosis of COPD in national and international surveys. , 2015, Chest.

[2]  A. Ruano-Raviña,et al.  Genetic Susceptibility, Residential Radon, and Lung Cancer in a Radon Prone Area , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  William Wheeler,et al.  Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer , 2014, Nature Genetics.

[4]  K. Torén,et al.  Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study , 2014, BMC Pulmonary Medicine.

[5]  Kayleigh Kew,et al.  Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. , 2014, The Cochrane database of systematic reviews.

[6]  D. Christiani,et al.  The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection. , 2014, Chest.

[7]  R. Zhai,et al.  Smoking and smoking cessation in relation to the development of co‐existing non‐small cell lung cancer with chronic obstructive pulmonary disease , 2014, International journal of cancer.

[8]  G. Rennert,et al.  Low Integrated DNA Repair Score and Lung Cancer Risk , 2013, Cancer Prevention Research.

[9]  Yun-Chul Hong,et al.  No Association between Tumor Necrosis Factor-alpha Gene Polymorphisms and Lung Cancer Risk , 2013, Environmental Health and Toxicology.

[10]  D. de Ruysscher,et al.  Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Yim,et al.  Inhaled corticosteroid use and risks of lung cancer and laryngeal cancer. , 2013, Respiratory medicine.

[12]  H. Brenner,et al.  Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. , 2013, The American journal of clinical nutrition.

[13]  A. M. Houghton,et al.  Mechanistic links between COPD and lung cancer , 2013, Nature Reviews Cancer.

[14]  T. Mihăescu,et al.  Lung cancer - a comorbidity in chronic obstructive pulmonary disease. , 2012, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[15]  A. Tardón,et al.  Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias , 2012, BMC Cancer.

[16]  H. Morgenstern,et al.  Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. , 2012, European journal of cancer.

[17]  Per Gustavsson,et al.  Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies , 2012, International journal of cancer.

[18]  Eric J Tchetgen Tchetgen,et al.  Genetic variants on 15q25.1, smoking, and lung cancer: an assessment of mediation and interaction. , 2012, American journal of epidemiology.

[19]  P. Brennan,et al.  Association between a Genome-Wide Association Study-Identified Locus and the Risk of Lung Cancer in Japanese Population , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[20]  B. Yawn,et al.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.

[21]  D. Luce,et al.  Investigation of occupational and environmental causes of respiratory cancers (ICARE): a multicenter, population-based case-control study in France , 2011, BMC public health.

[22]  R. Hopkins,et al.  How the genetics of lung cancer may overlap with COPD , 2011, Respirology.

[23]  P. Prorok,et al.  Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China. , 2011, Lung cancer.

[24]  M. Decamp,et al.  Lung cancer in chronic obstructive pulmonary disease: enhancing surgical options and outcomes. , 2011, American journal of respiratory and critical care medicine.

[25]  Y. Seto,et al.  [Current state of treatment for advanced gastric cancer]. , 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

[26]  Stijn Vansteelandt,et al.  Odds ratios for mediation analysis for a dichotomous outcome. , 2010, American journal of epidemiology.

[27]  Christopher I. Amos,et al.  Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5‐A3 genetic locus and lung cancer risk , 2010, Cancer.

[28]  Hongbing Shen,et al.  A 3′-Untranslated Region Polymorphism in IGF1 Predicts Survival of Non–Small Cell Lung Cancer in a Chinese Population , 2010, Clinical Cancer Research.

[29]  Hans Clevers,et al.  Coexistence of Quiescent and Active Adult Stem Cells in Mammals , 2010, Science.

[30]  D. Brenner,et al.  Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors , 2010, BMC Cancer.

[31]  A. Hackshaw,et al.  Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. , 2009, Journal of the National Cancer Institute.

[32]  C. Amos,et al.  Racial Differences in the Association Between SNPs on 15q25.1, Smoking Behavior, and Risk of Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  M. Etminan,et al.  Statins in COPD: a systematic review. , 2009, Chest.

[34]  J J Bax,et al.  COPD and cancer mortality: the influence of statins , 2009, Thorax.

[35]  M. Karagas,et al.  Lung Cancer in a U.S. Population with Low to Moderate Arsenic Exposure , 2009, Environmental health perspectives.

[36]  Paolo Vineis,et al.  International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. , 2008, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[37]  J. Engelhardt,et al.  The glandular stem/progenitor cell niche in airway development and repair. , 2008, Proceedings of the American Thoracic Society.

[38]  C. Abnet,et al.  Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. , 2008, The Lancet. Oncology.

[39]  S. Wacholder,et al.  Environment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancer , 2008, BMC public health.

[40]  J. Zieliński,et al.  Prevalence, severity and underdiagnosis of COPD in the primary care setting , 2008, Thorax.

[41]  Andrew J Thorley,et al.  Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease , 2007, International journal of chronic obstructive pulmonary disease.

[42]  D. Au,et al.  Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[43]  R. Vermeulen,et al.  Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers , 2006, Thorax.

[44]  D. Sackett,et al.  Accuracy of history, wheezing, and forced expiratory time in the diagnosis of chronic obstructive pulmonary disease , 2002, Journal of General Internal Medicine.

[45]  H. Morgenstern,et al.  Marijuana Use and the Risk of Lung and Upper Aerodigestive Tract Cancers: Results of a Population-Based Case-Control Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[46]  Hongye Liu,et al.  Predicting Survival within the Lung Cancer Histopathological Hierarchy Using a Multi-Scale Genomic Model of Development , 2006, PLoS medicine.

[47]  M. Spitz,et al.  An epidemiologic study of early onset lung cancer. , 2006, Lung cancer.

[48]  K. Jöckel,et al.  Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. , 2006, Lung cancer.

[49]  A. Schwartz,et al.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[50]  S. Duffy,et al.  The Liverpool Lung Project research protocol. , 2005, International journal of oncology.

[51]  S. Thibodeau,et al.  Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. , 2005, Chest.

[52]  M. Tockman,et al.  Genetic analysis of microsomal epoxide hydrolase gene and its association with lung cancer risk , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[53]  L. Trupin,et al.  Development and validation of a survey-based COPD severity score. , 2005, Chest.

[54]  A. Ruano-Raviña,et al.  Type of wine and risk of lung cancer: a case-control study in Spain , 2004, Thorax.

[55]  A. Andersen,et al.  The impact of smoking habits on lung cancer risk: 28 years' observation of 26,000 Norwegian men and women , 1996, Cancer Causes & Control.

[56]  J. Mulshine,et al.  The potential contributions of chronic inflammation to lung carcinogenesis. , 2003, Clinical lung cancer.

[57]  W. Seeger,et al.  Simvastatin Inhibits Inflammatory Properties of Staphylococcus aureus &agr;-Toxin , 2002, Circulation.

[58]  F. Speizer,et al.  Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. , 2002, American journal of epidemiology.

[59]  D. Christiani,et al.  Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. , 2002, Cancer research.

[60]  M. Loriot,et al.  Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. , 2001, Pharmacogenetics.

[61]  H. Wichmann,et al.  Case-control study on lung cancer and residential radon in western Germany. , 2001, American journal of epidemiology.

[62]  M. Kogevinas,et al.  Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. , 2000, Mutation research.

[63]  T L Petty,et al.  Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.

[64]  M. Decramer,et al.  Regulation of mucociliary clearance in health and disease. , 1999, The European respiratory journal.

[65]  G. Omenn,et al.  Strategies for recruitment to a population-based lung cancer prevention trial: the CARET experience with heavy smokers. Beta-Carotene and Retinol Efficacy Trial. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[66]  T. Hastie,et al.  Usefulness of generalized additive models , 1996, Statistical Methods in Medical Research.

[67]  R. Tibshirani,et al.  Generalized additive models for medical research , 1995, Statistical methods in medical research.

[68]  E. Wynder,et al.  Insulation, asbestos, smoking habits, and lung cancer cell types. , 1995, American journal of industrial medicine.

[69]  Mark R. Conaway,et al.  A random effects model for binary data , 1990 .

[70]  B. Armstrong,et al.  Ordinal regression models for epidemiologic data. , 1989, American journal of epidemiology.